HUP0200839A3 - Novel synthesis and crystallization of piperazine ring-containing compounds and pharmaceutical compositions containing them - Google Patents

Novel synthesis and crystallization of piperazine ring-containing compounds and pharmaceutical compositions containing them

Info

Publication number
HUP0200839A3
HUP0200839A3 HU0200839A HUP0200839A HUP0200839A3 HU P0200839 A3 HUP0200839 A3 HU P0200839A3 HU 0200839 A HU0200839 A HU 0200839A HU P0200839 A HUP0200839 A HU P0200839A HU P0200839 A3 HUP0200839 A3 HU P0200839A3
Authority
HU
Hungary
Prior art keywords
crystallization
pharmaceutical compositions
piperazine ring
novel synthesis
compositions containing
Prior art date
Application number
HU0200839A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HUP0200839A2 publication Critical patent/HUP0200839A2/hu
Publication of HUP0200839A3 publication Critical patent/HUP0200839A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HU0200839A 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds and pharmaceutical compositions containing them HUP0200839A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13004799P 1999-04-19 1999-04-19

Publications (2)

Publication Number Publication Date
HUP0200839A2 HUP0200839A2 (en) 2002-08-28
HUP0200839A3 true HUP0200839A3 (en) 2003-05-28

Family

ID=22442814

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200839A HUP0200839A3 (en) 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds and pharmaceutical compositions containing them

Country Status (16)

Country Link
JP (1) JP2004500324A (hu)
KR (1) KR20020019902A (hu)
CN (4) CN1356903A (hu)
CA (1) CA2368815A1 (hu)
CZ (1) CZ20013658A3 (hu)
HK (1) HK1044116A1 (hu)
HR (1) HRP20010747A2 (hu)
HU (1) HUP0200839A3 (hu)
IL (1) IL146023A0 (hu)
PL (1) PL366289A1 (hu)
RU (1) RU2001128229A (hu)
SK (1) SK14672001A3 (hu)
TR (1) TR200103028T2 (hu)
WO (1) WO2000062782A1 (hu)
YU (1) YU74101A (hu)
ZA (1) ZA200108220B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6019900A (en) * 1999-11-24 2001-06-04 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
ES2246161B1 (es) * 2004-07-22 2007-04-01 Medichem, S.A. Proceso mejorado para la fabricacion de mirtazapina.
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 2−(4−メチル−2−フェニルピペラジン−1−イル)−3−シアノピリジンの製造方法
JP5192707B2 (ja) * 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
EP2146993B1 (en) 2007-04-11 2015-08-05 Merck Sharp & Dohme B.V. A method for the preparation of mirtazapine
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
KR101485418B1 (ko) * 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法
CN108191873B (zh) * 2018-01-08 2021-09-24 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Also Published As

Publication number Publication date
CA2368815A1 (en) 2000-10-26
CZ20013658A3 (cs) 2002-08-14
IL146023A0 (en) 2002-07-25
HRP20010747A2 (en) 2002-12-31
WO2000062782A1 (en) 2000-10-26
SK14672001A3 (sk) 2002-11-06
TR200103028T2 (tr) 2002-01-21
KR20020019902A (ko) 2002-03-13
JP2004500324A (ja) 2004-01-08
HK1044116A1 (zh) 2002-10-11
PL366289A1 (en) 2005-01-24
YU74101A (sh) 2004-09-03
CN1680365A (zh) 2005-10-12
RU2001128229A (ru) 2003-07-10
CN1679586A (zh) 2005-10-12
HUP0200839A2 (en) 2002-08-28
ZA200108220B (en) 2006-02-26
CN1356903A (zh) 2002-07-03
CN1680374A (zh) 2005-10-12

Similar Documents

Publication Publication Date Title
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
HUP0003929A3 (en) Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them
HUP9901960A3 (en) Pharmaceutical compositions containing crystalline ziprasidone and process for preparation of the crystals
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0400998A3 (en) Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
HUP0002037A3 (en) Hydroximic acid derivatives, use of them for producing pharmaceutical compositions suitable for inhibiting matrix metalloproteinas and pharmaceutical compositions containing the compounds
HK1046688A1 (zh) 喹唑啉化合物和含有喹唑啉化合物的藥物組合物
HUP0200839A3 (en) Novel synthesis and crystallization of piperazine ring-containing compounds and pharmaceutical compositions containing them
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP0201334A3 (en) Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same
HUP0104922A2 (en) New piperazine and piperidine derivatives and pharmaceutical compositions containing them and processes for their preparation
HUP0202255A3 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
IL133223A0 (en) Novel 2-(iminomethyl) amino-phenyl derivatives preparation application as medicines and compositions containing same
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
HUP0201714A3 (en) Substituted heterocyclic compounds and pharmaceutical compositions containing them
HUP0200580A3 (en) Polymorphic crystalline forms of celecoxib, process their preparation and pharmaceutical compositions containing them
HUP0402088A3 (en) Substituted piperazine and piperidine compounds pharmaceutical compositions containing them and their use for the preparation of a medicament for inhibiting fatty acid oxidation
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
HUP0200747A2 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0204069A3 (en) Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
HUP0203884A3 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them
HUP9801382A3 (en) Piperazine derivatives as neurokinin antagonists and pharmaceutical compositions containing these compounds
HUP0004345A3 (en) Novel oral pharmaceutical compositions containing from carvedilol

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees